Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -45.13x is 89% below its 4-year average of -23.86x, near the low end of its 4-year range (-45.13x–8.85x).
135.54% below its 12-month average of -19.16x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -26.89x.
INTEREST COVERAGE RATIO
-45.13x
INTEREST COVERAGE RATIO AVG TTM
-19.16x
INTEREST COVERAGE RATIO AVG 3Y
-22.59x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-135.54%
CURRENT VS 3Y AVG
-99.75%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
-699.47%
vs the sector median at left
Orchestra BioMed Holdings, Inc.
Market Cap
$351.20M
Interest Coverage Ratio
-45.13x
TTM Avg
-19.16x
3Y Avg
-22.59x
5Y Avg
N/A
Market Cap
$353.45M
Interest Coverage Ratio
-11.11x
TTM Avg
316.78x
3Y Avg
4209.35x
5Y Avg
3030.57x
Market Cap
$354.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$355.77M
Interest Coverage Ratio
-3.05x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
Market Cap
$356.65M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$356.86M
Interest Coverage Ratio
3.07x
TTM Avg
2.31x
3Y Avg
3.74x
5Y Avg
3.74x
Market Cap
$359.46M
Interest Coverage Ratio
-12.13x
TTM Avg
372.18x
3Y Avg
320.22x
5Y Avg
320.22x
Market Cap
$364.53M
Interest Coverage Ratio
-26.33x
TTM Avg
2025.11x
3Y Avg
2025.11x
5Y Avg
2025.11x
Market Cap
$333.56M
Interest Coverage Ratio
-0.37x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.39x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | $351.20M | -45.13x | -19.16x | -22.59x | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.45M | -11.11x | 316.78x | 4209.35x | 3030.57x |
| Relmada Therapeutics, Inc. (RLMD)vs › | $354.01M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $355.77M | -3.05x | 0.61x | 0.61x | 0.61x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $356.65M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $356.86M | 3.07x | 2.31x | 3.74x | 3.74x |
| Ocugen, Inc. (OCGN)vs › | $359.46M | -12.13x | 372.18x | 320.22x | 320.22x |
| Opus Genetics, Inc. (IRD)vs › | $364.53M | -26.33x | 2025.11x | 2025.11x | 2025.11x |
| Agenus Inc. (AGEN)vs › | $333.56M | -0.37x | 0.39x | 0.39x | 0.39x |
| Cabaletta Bio, Inc. (CABA)vs › | $328.56M | -85.95x | N/A | N/A | N/A |
Interest Coverage
-45.1x
Debt/Equity
2.41
Current Ratio
8.26
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -26.89x |
| 2025-12-31 | 8.85x |
| 2025-09-30 | -39.44x |
| 2023-03-31 | -32.89x |
| 2022-06-30 | -31.03x |
| 2022-03-31 | -21.73x |
